- Home
- BMRN vs JHX Comparison
BMRN vs JHX Comparison
Compare BMRN & JHX Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.
- Machine Learning Prediction
- ML Decision
- BMRN
- JHX
- Stock Information
- Founded
- BMRN 1996
- JHX 1888
- Country
- BMRN United States
- JHX Ireland
- Employees
- BMRN N/A
- JHX N/A
- Industry
- BMRN Biotechnology: Pharmaceutical Preparations
- JHX Building Materials
- Sector
- BMRN Health Care
- JHX Industrials
- Exchange
- BMRN Nasdaq
- JHX Nasdaq
- Market Cap
- BMRN 10.0B
- JHX 11.8B
- IPO Year
- BMRN 1999
- JHX N/A
- Fundamental
- Price
- BMRN $51.52
- JHX $17.30
- Analyst Decision
- BMRN Buy
- JHX Strong Buy
- Analyst Count
- BMRN 19
- JHX 9
- Target Price
- BMRN $90.26
- JHX $28.00
- AVG Volume (30 Days)
- BMRN 2.8M
- JHX 5.6M
- Earning Date
- BMRN 10-27-2025
- JHX 11-18-2025
- Dividend Yield
- BMRN N/A
- JHX N/A
- EPS Growth
- BMRN 59.53
- JHX N/A
- EPS
- BMRN 2.68
- JHX 0.77
- Revenue
- BMRN $3,094,001,000.00
- JHX $3,785,500,000.00
- Revenue This Year
- BMRN $13.32
- JHX $21.70
- Revenue Next Year
- BMRN $7.51
- JHX $16.85
- P/E Ratio
- BMRN $19.20
- JHX $29.58
- Revenue Growth
- BMRN 12.39
- JHX N/A
- 52 Week Low
- BMRN $50.76
- JHX $16.66
- 52 Week High
- BMRN $73.51
- JHX $37.65
- Technical
- Relative Strength Index (RSI)
- BMRN 40.53
- JHX 26.09
- Support Level
- BMRN $51.80
- JHX $21.47
- Resistance Level
- BMRN $53.49
- JHX $22.49
- Average True Range (ATR)
- BMRN 1.84
- JHX 0.65
- MACD
- BMRN -0.08
- JHX -0.54
- Stochastic Oscillator
- BMRN 12.58
- JHX 11.03
About BMRN BioMarin Pharmaceutical Inc.
BioMarin is a global biotechnology company focused on developing and commercializing therapies for rare genetic diseases. BioMarin specializes in enzyme replacement therapies, gene therapies, and other advanced treatments designed to address complex genetic disorders. The company has eight approved therapies for conditions including achondroplasia, phenylketonuria, hemophilia, and mucopolysaccharidosis. BioMarin has an expanding, yet relatively early-stage, pipeline of treatments in development across skeletal conditions and enzyme therapies.
About JHX James Hardie Industries plc (Ireland)
James Hardie is a manufacturer of fiber cement-based building products, selling primarily to the residential construction industry. North America is the primary geography, generating about 80% of group earnings. Here, it is the largest manufacturer of fiber cement, which is mainly used for exterior siding on houses. Following the Azek acquisition in 2025, it also produces wooden composite decking materials, siding trims, and accessories for outdoor areas including stair and deck railing. Businesses in Australia, New Zealand, and Europe, make up the rest of earnings.